ADVA
16.6.2022 09:02:14 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that Quickline has deployed its FSP 150 aggregation solution to offer high-speed residential and enterprise services across the hardest-to-reach areas in Yorkshire and Lincolnshire. The innovative new network utilizes 5G wireless and FTTP for the last mile. Combined with ADVA’s MEF 3.0-certified 100Gbit/s technology, this enables Quickline to rapidly expand the delivery of ultra-fast, highly available broadband to more remote locations across the region. Temperature-hardened and simple to deploy, ADVA’s compact edge solution provides pre-activation testing and features the highly accurate synchronization capabilities vital for 5G services. ADVA’s partner, Nomios, played a key role in the deployment, planning and designing of the new infrastructure as well as providing project management, network management services and ongoing support.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220615005587/en/
“Our mission is to give customers access to gigabit-capable broadband in the hardest-to-reach rural areas of the UK. To do that, we’ve harnessed the most advanced aggregation device and taken an innovative approach to last-mile connectivity. By leveraging the flexibility and power of ADVA’s FSP 150 to link our 5G-based services to PoPs, we can deliver lightning-fast broadband to more rural communities than ever before,” said Sean Royce, CEO of Quickline. ”Working with trusted and proven partners such as ADVA and Nomios with their strong customer-first ethos was also important to us in our decision making.”
Supported by the Building Digital UK program, Quickline’s expanded network is helping to connect some of Britain’s hardest-to-reach places. Built on the high-density ADVA FSP 150-XG400 Series , the infrastructure enables 100Gbit/s connectivity in the national network as well as the distribution of the highly precise phase and frequency synchronization needed for 5G. For smaller nodes, Quickline has also deployed the FSP 150-XG100Pro Series . Both solutions bring together a rich set of programmability and security features contained within a compact and environmentally hardened case. What’s more, with 24/7 monitoring from Nomios, any faults can be proactively identified and rectified with minimal impact on end users.
“We’re pleased to be supporting Quickline with its goal of offering high-speed internet to those living and working in underserved areas. With more people than ever working from home, it’s vital to close the digital divide and ensure that families and businesses can benefit from the same high-quality services as those in urban areas,” commented Hartmut Müller-Leitloff, SVP of sales, EMEA at ADVA. “Our FSP 150 family of carrier-class packet devices is the perfect fit for Quickline’s expanding network. Designed to deliver high-density transport, aggregation and demarcation of 5G and MEF 3.0 CE services, our solutions ensure fast and reliable fixed-line or wireless connectivity. We’re looking forward to helping Quickline continue to grow with support from us and our partner Nomios.”
“Homes and businesses now expect and depend on fast, reliable broadband. That’s why Quickline is harnessing our expertise with ADVA’s packet edge technology to build a new high-speed residential and enterprise network. The opportunity for strategic growth is now firmly in place with the ability to scale services at the edge and extend reach to customers in hard-to-reach locations. This has been achieved in a highly reliable, time- and cost-efficient way,” said Richard Butcher, MD of UK&I at Nomios. “With our monitoring service, ongoing management, maintenance and training, Quickline is well prepared for the future. Working together, Nomios and ADVA helped Quickline to combine their 5G technologies and best-of-breed access solutions, creating an extremely innovative and efficient network architecture that will deliver on present day and future customer expectations across Yorkshire, Lincolnshire and beyond.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
About Nomios
Nomios are a cyber security and networking solutions provider for global enterprises, telecommunications operators and service providers. They combine technologies, processes and the best human expertise to create next generation services and solutions. Their service quality and operational excellence results in the highest customer satisfaction in the market. www.nomios.co.uk .
About Quickline
Quickline is focussed on delivering improved broadband connectivity in rural areas of the north of England and beyond where a significant digital divide remains and many hundreds of thousands of premises are in desperate need of increased broadband speeds. The East Yorkshire-based firm is an innovative forward-thinking Internet Service Provider (ISP) with its heritage in fixed wireless, but its network includes increasing amounts of full fibre connectivity, as well as rural-delivered 5G technology. Its aim is to be the leading UK-dedicated, rural broadband infrastructure provider, delivering innovative, flexible and hybrid solutions that can address the millions of premises ignored by previous commercial rollouts for many years to come. They believe in ultrafast internet for all, no matter where you live or work. www.quickline.co.uk .
Published by:
ADVA Optical Networking SE, Munich, Germany
View source version on businesswire.com: https://www.businesswire.com/news/home/20220615005587/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom